Dipeptidyl Peptidase IV Inhibition in Animal Models of Diabetes

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Timothy J. Kieffer, Christopher H.S. McIntosh, Raymond A. Pederson · Endocrinology · 1995 · 1.1K citations

Life Sciences, Biochemistry, Endocrinology +17

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

M. Gutniak, Jens J. Holst, Bo Åhrén et al. · New England Journal of Medicine · 1992 · 875 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes

Bo Åhrén, Erik Simonsson, Hillevi Larsson et al. · Diabetes Care · 2002 · 423 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Degradation of Endogenous and Exogenous Gastric Inhibitory Polypeptide in Healthy and in Type 2 Diabetic Subjects as Revealed Using a New Assay for the Intact Peptide¹

Carolyn F. Deacon, Michael A. Nauck, Juris J. Meier et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 400 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4

TracyAnn Perry, Norman J. Haughey, Mark P. Mattson et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 374 citations

Life Sciences, Neuroscience, Pharmacology +17